Literature DB >> 18773051

Radical surgery: vascular and pancreatic resection for cholangiocarcinoma.

Y Nimura1.   

Abstract

Recent progress in vascular surgical techniques has made it possible to combine liver and portal vein and/or hepatic artery (HA) or retrohepatic inferior vena cava (IVC) resection and reconstruction in cases of locally advanced cholangiocarcinoma. Reports of the success of this difficult surgery have been published. Aggressive Japanese surgeons have applied hepatopancreatoduodenectomy (HPD) not just in cases of advanced gallbladder cancer, but also in locally advanced cholangiocarcinoma with or without superficial spread. The above extended surgeries were associated with high postoperative morbidity and mortality, but recent progress in perioperative management and surgical techniques has improved the outcome of these types of surgery. Combined portal vein and liver resection provides R0 resection and contributes to longer survival in resected patients with locally advanced cholangiocarcinoma than in unresected patients. Portal vein invasion is a strong prognostic factor of cholangiocarcinoma and the actual number of 5-year survivors is limited. The number of clinical cases of liver resection combined with IVC or HA resection and reconstruction is still limited, and therefore the long-term survival benefit from these procedures has not been clarified. HPD carried high morbidity and mortality rates in the 1990s, but the outcome has been improving and an increasing number of 5-year survivors has been reported. Although the clinical value of the above extended surgeries has not been evaluated prospectively, with the increasing number of retrospective studies it has been concluded that combined liver and portal vein and/or HA or IVC resection or HPD could be indicated for selected patients with locally advanced cholangiocarcinoma.

Entities:  

Year:  2008        PMID: 18773051      PMCID: PMC2504372          DOI: 10.1080/13651820801992682

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  35 in total

1.  Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract.

Authors:  Y Nimura; N Hayakawa; J Kamiya; S Maeda; S Kondo; A Yasui; S Shionoya
Journal:  Hepatogastroenterology       Date:  1991-04

2.  Portal vein resection for hilar cholangiocarcinoma.

Authors:  Alan W Hemming; Robin D Kim; Kristin L Mekeel; Shiro Fujita; Alan I Reed; David P Foley; Richard J Howard
Journal:  Am Surg       Date:  2006-07       Impact factor: 0.688

3.  Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?

Authors:  M Miyazaki; H Ito; K Nakagawa; S Ambiru; H Shimizu; Y Shimizu; A Kato; S Nakamura; H Omoto; N Nakajima; F Kimura; T Suwa
Journal:  Surgery       Date:  1998-02       Impact factor: 3.982

4.  Portal vein replacement by hepatic vein transposition.

Authors:  T Lorf; U Hanack; B Ringe
Journal:  Am J Surg       Date:  1997-09       Impact factor: 2.565

5.  Carcinoma of the common bile duct with superficial spread to the intrahepatic segmental bile ducts: a case report.

Authors:  M Kato; Y Nimura; J Kamiya; S Kondo; M Nagino; M Miyachi; M Kanai; H Igaki; S Maeda
Journal:  Am Surg       Date:  1997-11       Impact factor: 0.688

6.  Vascular problems in upper abdominal cancer surgery.

Authors:  J G Fotner; D W Kinne; D K Kim; E B Castro; M H Shiu; E J Beattie
Journal:  Arch Surg       Date:  1974-08

7.  Is major hepatectomy with pancreatoduodenectomy justified for advanced biliary malignancy?

Authors:  Shiro Miwa; Akira Kobayashi; Yasuhiko Akahane; Takenari Nakata; Motohiro Mihara; Kei Kusama; Shinichiro Ogawa; Junpei Soeda; Shinichi Miyagawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-03-27

8.  Hepatopancreatoduodenectomy: its suitability for bile duct cancer versus gallbladder cancer.

Authors:  Yuji Kaneoka; Akihiro Yamaguchi; Masatoshi Isogai
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-03-27

9.  Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.

Authors:  Taizen Urahashi; Masakazu Yamamoto; Takehito Ohtsubo; Hideo Katsuragawa; Satoshi Katagiri; Ken Takasaki
Journal:  Hepatogastroenterology       Date:  2007-03

10.  Right hepatectomy combined with retrohepatic caval resection, using a left renal vein patch graft for advanced cholangiocarcinoma.

Authors:  Hisashi Kurosawa; Fumio Kimura; Hiroshi Ito; Hiroaki Shimizu; Akira Togawa; Masayuki Otsuka; Hiroyuki Yoshidome; Atsushi Kato; Masaru Miyazaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2004
View more
  3 in total

1.  Extra-Hepatic Bile Duct Resection: an Insight in the Management of Gallbladder Cancer.

Authors:  Durgatosh Pandey; Pankaj Kumar Garg; N M L Manjunath; Jyoti Sharma
Journal:  J Gastrointest Cancer       Date:  2015-09

Review 2.  Evolving role of vascular resection and reconstruction in hepatic surgery for malignancy.

Authors:  Kristin L Mekeel; Alan W Hemming
Journal:  Hepat Oncol       Date:  2013-12-20

3.  Decorin-mediated inhibition of cholangiocarcinoma cell growth and migration and promotion of apoptosis are associated with E-cadherin in vitro.

Authors:  Xiang Yu; Yanfen Zou; Quan Li; Yonghuan Mao; Hui Zhu; Guangming Huang; Guozhong Ji; Xiagang Luo; Chunzhao Yu; Xiuhua Zhang
Journal:  Tumour Biol       Date:  2013-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.